Cargando…

Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis

[Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All o...

Descripción completa

Detalles Bibliográficos
Autores principales: Konduri, Srihari, Bhargavi, Dodda, Prashanth, Jyothi, Krishna, Vagolu Siva, Sriram, Dharmarajan, Rao, Koya Prabhakara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818581/
https://www.ncbi.nlm.nih.gov/pubmed/33490825
http://dx.doi.org/10.1021/acsomega.0c05690
_version_ 1783638864615702528
author Konduri, Srihari
Bhargavi, Dodda
Prashanth, Jyothi
Krishna, Vagolu Siva
Sriram, Dharmarajan
Rao, Koya Prabhakara
author_facet Konduri, Srihari
Bhargavi, Dodda
Prashanth, Jyothi
Krishna, Vagolu Siva
Sriram, Dharmarajan
Rao, Koya Prabhakara
author_sort Konduri, Srihari
collection PubMed
description [Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All of these compounds were characterized by (1)H and (13)C nuclear magnetic resonance spectroscopy, CHN analysis, and high-resolution mass spectra for confirmation of the structures. Two compounds were also characterized by single-crystal X-ray diffraction analysis to confirm the structures obtained by spectral analysis. All these 30 compounds were tested for their in vitro antimycobacterial activity using the microplate alamar blue assay method against Mycobacterium tuberculosis. Five compounds have shown good minimum inhibitory concentration (MIC) values with low cytotoxicity when compared with the reference drugs. Moreover, some of the compounds have high MIC values compared with isoniazid, rifampicin, and so forth and also had shown good reign in the spread of bacteria by the nutrient starvation model. These antimycobacterial activity results have shown a good correlation with molecular docking model analysis with the inhibitors MurB by exhibiting strong interactions. Some of these compounds could be promising candidates against M. tuberculosis for future preclinical agent drug development.
format Online
Article
Text
id pubmed-7818581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-78185812021-01-22 Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis Konduri, Srihari Bhargavi, Dodda Prashanth, Jyothi Krishna, Vagolu Siva Sriram, Dharmarajan Rao, Koya Prabhakara ACS Omega [Image: see text] A series of 30 novel diamino phenyl chloropicolinate fettered carboxamides, urea, and thiourea derivatives were synthesized by coupling of methyl 4-amino-6-(2-aminophenyl)-3-chloropyridine-2-carboxylate with different acid chlorides, urea, and thiourea moieties, respectively. All of these compounds were characterized by (1)H and (13)C nuclear magnetic resonance spectroscopy, CHN analysis, and high-resolution mass spectra for confirmation of the structures. Two compounds were also characterized by single-crystal X-ray diffraction analysis to confirm the structures obtained by spectral analysis. All these 30 compounds were tested for their in vitro antimycobacterial activity using the microplate alamar blue assay method against Mycobacterium tuberculosis. Five compounds have shown good minimum inhibitory concentration (MIC) values with low cytotoxicity when compared with the reference drugs. Moreover, some of the compounds have high MIC values compared with isoniazid, rifampicin, and so forth and also had shown good reign in the spread of bacteria by the nutrient starvation model. These antimycobacterial activity results have shown a good correlation with molecular docking model analysis with the inhibitors MurB by exhibiting strong interactions. Some of these compounds could be promising candidates against M. tuberculosis for future preclinical agent drug development. American Chemical Society 2021-01-07 /pmc/articles/PMC7818581/ /pubmed/33490825 http://dx.doi.org/10.1021/acsomega.0c05690 Text en © 2021 The Authors. Published by American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Konduri, Srihari
Bhargavi, Dodda
Prashanth, Jyothi
Krishna, Vagolu Siva
Sriram, Dharmarajan
Rao, Koya Prabhakara
Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title_full Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title_fullStr Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title_full_unstemmed Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title_short Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
title_sort design and synthesis of “chloropicolinate amides and urea derivatives” as novel inhibitors for mycobacterium tuberculosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818581/
https://www.ncbi.nlm.nih.gov/pubmed/33490825
http://dx.doi.org/10.1021/acsomega.0c05690
work_keys_str_mv AT kondurisrihari designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis
AT bhargavidodda designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis
AT prashanthjyothi designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis
AT krishnavagolusiva designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis
AT sriramdharmarajan designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis
AT raokoyaprabhakara designandsynthesisofchloropicolinateamidesandureaderivativesasnovelinhibitorsformycobacteriumtuberculosis